• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX AVM; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX AVM; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number 105-7100-080
Medical Device Problem Code Display or Visual Feedback Problem (1184)
Health Effect - Clinical Codes No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/26/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received a report that the onyx was mixed for 30 minutes and used immediately upon preparation.The speed setting on the shaker was set to high, and the vial did not sit more than 5 minutes after preparation.The physician did not heat, shake, and re-heat the onyx vials prior to aspiration.However, there was zero visibility of the onyx even though it was a very small injection.There was no injury to the patient reported as a result of the event.The patient was undergoing surgery for treatment of an arteriovenous malformation (avm) of the eloquent region.It was noted the patient's vessel tortuosity was moderate.
 
Additional Manufacturer Narrative
B5: review of the video provided by the site showed an onyx cast on the image taken during microcatheter.Since images under fluoroscopy are lacking one can not confirm that onyx was not visible during the injection.Since the preparation of the device was done per instructions for use (ifu), examination of the vial involved in this complaint is highly recommended to ensure that the product was within specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received indicated the remaining onyx had been discarded after the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX AVM
Common Device Name
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key10751861
Report Number2029214-2020-01067
Device Sequence Number3814255
Product Code MFE
UDI-Device Identifier00847536006188
UDI-Public00847536006188
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P030004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/02/2023
Device Model Number105-7100-080
Device Catalogue Number105-7100-080
Device Lot NumberB068684
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/26/2020
Supplement Date Received by Manufacturer02/15/2021
Initial Report FDA Received Date10/28/2020
Supplement Report FDA Received Date02/16/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-